IP Library Granted Patent US 11,814,668
Granted Patent B2
US 11,814,668 · App. 17/172,726 · Granted Nov 14, 2023

Detection of

Inventors: Leah Wickenberg (Reno, NV); Avneet K. Chhabra (Sparks, NV); Katherine E. Fisher (Reno, NV); William F. McCoy (Reno, NV)
Assignee: Phigenics, LLC
C12Q1/045C12Q1/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,814,668
App. No.
17/172,726
Granted
Nov 14, 2023
Kind
B2
Abstract

To determine the presence of Mycobacterium in an environment, a sample from the environment can be plated onto a growth medium that is selective for Mycobacterium . The agar based growth medium can include a high concentration of crystal violet, in excess of 0.5 μg/ml. The process may be made further selective for Mycobacterium by treating the sample with sodium dodecyl sulfate containing glycine hydrochloride for at least 4 minutes at room temperature, prior to plating. Mycobacterium colonies will generally appear white while other colonies will generally appear stained purple or another color.

Claims (12)

1. A method for determining the presence of Mycobacterium in a sample, comprising:

(A) obtaining a sample from the environment;

(B) treating the sample with a compound containing sodium dodecyl sulfate and glycine hydrochloride, wherein the compound comprises 1-5 mM glycine hydrochloride and 0.1%-1.0% sodium dodecyl sulfate;

(C) plating at least a portion of the treated sample onto a growth medium;

(D) incubating a plated sample for an incubation period; and

(E) after the incubation period, inspecting one or more bacterial growth colonies to determine the presence of Mycobacterium in the environment;

wherein the growth medium comprises agar, one or more amino acid and nitrogenous supplementation elements, one or more trace elements and vitamins, one or more carbon sources, one or more neutralizing agents, and crystal violet, wherein the crystal violet is in an amount in excess of 0.5 μg/ml.

2. The method of claim 1 wherein the crystal violet is in an amount in excess of 1.0 μg/ml.

3. The method of claim 1 wherein the crystal violet is in an amount in excess of 2.0 μg/ml.

4. The method of claim 1 wherein the crystal violet is in an amount in excess of 0.5 μg/ml and up to 5.0 μg/ml.

5. The method of claim 1 comprising treating the sample with the compound containing sodium dodecyl sulfate and glycine hydrochloride for at least 4 minutes at room temperature.

6. The method of claim 1 wherein the growth medium comprises proteose peptone, casamino acids, yeast extract, dextrose, soluble starch, dipotassium phosphate, magnesium sulfate, and sodium pyruvate.

Assignments (3)
SECURITY INTEREST Recorded Jun 18, 2026
From: PHIGENICS, LLC
To: MONROE CAPITAL MANAGEMENT ADVISORS, LLC
Reel/Frame 075002/0504 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 10, 2023
From: FISHER, KATHERINE E.
To: PHIGENICS, LLC
Reel/Frame 065170/0025 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 10, 2023
From: CHHABRA, AVNEET K.
To: PHIGENICS, LLC
Reel/Frame 065170/0239 →
Continuity (2)
Provisional Application 62976631 · Feb 14, 2020
Related Publication 20210254124A1 · Aug 19, 2021
Cited By (1)
US 12,649,945